Form 4 Filing for Beam Therapeutics Inc. - Officer Sale of Common Stock

This filing reports a transaction by Ciaramella Giuseppe, President of Beam Therapeutics Inc. On April 1, 2026, Mr. Giuseppe sold 11,810 shares of common stock at a price of $24.58 per share. This sale was part of a non-discretionary transaction to cover tax withholding obligations upon the vesting of restricted stock units. The shares were sold under a Rule 10b5-1 trading plan adopted on May 23, 2023. Following this transaction, Mr. Giuseppe owns 218,406 shares of common stock.